The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma

Molecular targeted therapy is a standard treatment for patients with advanced renal cell carcinoma (RCC). Sunitinib is one of the most common molecular-targeted drugs for metastatic RCC. Molecular mechanisms of sunitinib resistance in RCC cells is still ambiguous. The microRNA (miRNA) expression sig...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Goto, Yusuke, Kurozumi, Akira, Nohata, Nijiro, Kojima, Satoko, Matsushita, Ryosuke, Yoshino, Hirofumi, Yamazaki, Kazuto, Ishida, Yasuo, Ichikawa, Tomohiko, Naya, Yukio, Seki, Naohiko
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312296/
https://ncbi.nlm.nih.gov/pubmed/27487138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10887
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars